These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35628578)

  • 41. Anomalous single-subject based morphological cortical networks in drug-naive, first-episode major depressive disorder.
    Chen T; Kendrick KM; Wang J; Wu M; Li K; Huang X; Luo Y; Lui S; Sweeney JA; Gong Q
    Hum Brain Mapp; 2017 May; 38(5):2482-2494. PubMed ID: 28176413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings.
    Kaufmann FN; Costa AP; Ghisleni G; Diaz AP; Rodrigues ALS; Peluffo H; Kaster MP
    Brain Behav Immun; 2017 Aug; 64():367-383. PubMed ID: 28263786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cortical Thickness in Individuals at High Familial Risk of Mood Disorders as They Develop Major Depressive Disorder.
    Papmeyer M; Giles S; Sussmann JE; Kielty S; Stewart T; Lawrie SM; Whalley HC; McIntosh AM
    Biol Psychiatry; 2015 Jul; 78(1):58-66. PubMed ID: 25534753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder.
    Na KS; Chang HS; Won E; Han KM; Choi S; Tae WS; Yoon HK; Kim YK; Joe SH; Jung IK; Lee MS; Ham BJ
    PLoS One; 2014; 9(1):e85425. PubMed ID: 24465557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased prefrontal and parietal cortical thickness does not correlate with anhedonia in patients with untreated first-episode major depressive disorders.
    Yang XH; Wang Y; Huang J; Zhu CY; Liu XQ; Cheung EF; Xie GR; Chan RC
    Psychiatry Res; 2015 Oct; 234(1):144-51. PubMed ID: 26382106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Combined Study of SLC6A15 Gene Polymorphism and the Resting-State Functional Magnetic Resonance Imaging in First-Episode Drug-Naive Major Depressive Disorder.
    Wang L; Liu Z; Cao X; Li J; Zhang A; Sun N; Yang C; Zhang K
    Genet Test Mol Biomarkers; 2017 Sep; 21(9):523-530. PubMed ID: 28915082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortical thickness in major depressive disorder: A systematic review and meta-analysis.
    Suh JS; Schneider MA; Minuzzi L; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():287-302. PubMed ID: 30118825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study combining whole-exome sequencing and structural neuroimaging analysis for major depressive disorder.
    Han KM; Han MR; Kim A; Kang W; Kang Y; Kang J; Tae WS; Cho Y; Ham BJ
    J Affect Disord; 2020 Feb; 262():31-39. PubMed ID: 31706157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings.
    Chagas MHN; Tumas V; Pena-Pereira MA; Machado-de-Sousa JP; Carlos Dos Santos A; Sanches RF; Hallak JEC; Crippa JAS
    J Psychiatr Res; 2017 Jul; 90():40-45. PubMed ID: 28222355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex-specific alterations of cortical morphometry in treatment-naïve patients with major depressive disorder.
    Hu X; Zhang L; Liang K; Cao L; Liu J; Li H; Gao Y; Hu X; Hu Y; Kuang W; Sweeney JA; Gong Q; Huang X
    Neuropsychopharmacology; 2022 Oct; 47(11):2002-2009. PubMed ID: 34980883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group.
    Leerssen J; Blanken TF; Pozzi E; Jahanshad N; Aftanas L; Andreassen OA; Baune BT; Brack I; Carballedo A; Ching CRK; Dannlowski U; Dohm K; Enneking V; Filimonova E; Fingas SM; Frodl T; Godlewska BR; Goltermann J; Gotlib IH; Grotegerd D; Gruber O; Harris MA; Hatton SN; Hawkins E; Hickie IB; Jaworska N; Kircher T; Krug A; Lagopoulos J; Lemke H; Li M; MacMaster FP; McIntosh AM; McLellan Q; Meinert S; Mwangi B; Nenadić I; Osipov E; Portella MJ; Redlich R; Repple J; Sacchet MD; Sämann PG; Simulionyte E; Soares JC; Walter M; Watanabe N; Whalley HC; Yüksel D; Veltman DJ; Thompson PM; Schmaal L; Van Someren EJW
    Transl Psychiatry; 2020 Dec; 10(1):425. PubMed ID: 33293520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroimaging markers of adolescent depression in the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study.
    Meruelo AD; Brumback T; Nagel BJ; Baker FC; Brown SA; Tapert SF
    J Affect Disord; 2021 May; 287():380-386. PubMed ID: 33836366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients.
    Lucafò M; Granata S; Bonten EJ; McCorkle R; Stocco G; Caletti C; Selvestrel D; Cozzarolo A; Zou C; Cuzzoni E; Pasini A; Montini G; Gambaro G; Decorti G; Evans W; Zaza G
    Clin Transl Sci; 2021 May; 14(3):964-975. PubMed ID: 33382913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide.
    Murphy TM; Crawford B; Dempster EL; Hannon E; Burrage J; Turecki G; Kaminsky Z; Mill J
    Transl Psychiatry; 2017 Jan; 7(1):e989. PubMed ID: 28045465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder.
    Nguyen L; Kakeda S; Katsuki A; Sugimoto K; Otsuka Y; Ueda I; Igata R; Watanabe K; Kishi T; Iwata N; Korogi Y; Yoshimura R
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):785-794. PubMed ID: 30406404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between reduced white matter integrity in the corpus callosum and serotonin transporter gene DNA methylation in medication-naive patients with major depressive disorder.
    Won E; Choi S; Kang J; Kim A; Han KM; Chang HS; Tae WS; Son KR; Joe SH; Lee MS; Ham BJ
    Transl Psychiatry; 2016 Aug; 6(8):e866. PubMed ID: 27505229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of major depressive disorder using a multiparametric classification approach based on high resolution structural images.
    Qiu L; Huang X; Zhang J; Wang Y; Kuang W; Li J; Wang X; Wang L; Yang X; Lui S; Mechelli A; Gong Q
    J Psychiatry Neurosci; 2014 Mar; 39(2):78-86. PubMed ID: 24083459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Serotonin Transporter Gene AluJb Methylation with Major Depression, Amygdala Responsiveness, 5-HTTLPR/rs25531 Polymorphism, and Stress.
    Schneider I; Kugel H; Redlich R; Grotegerd D; Bürger C; Bürkner PC; Opel N; Dohm K; Zaremba D; Meinert S; Schröder N; Straßburg AM; Schwarte K; Schettler C; Ambrée O; Rust S; Domschke K; Arolt V; Heindel W; Baune BT; Zhang W; Dannlowski U; Hohoff C
    Neuropsychopharmacology; 2018 May; 43(6):1308-1316. PubMed ID: 29114103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cumulative effect of genetic polymorphisms on depression and brain structural integrity.
    Kostic M; Canu E; Agosta F; Munjiza A; Novakovic I; Dobricic V; Maria Ferraro P; Miler Jerkovic V; Pekmezovic T; Lecic Tosevski D; Filippi M
    Hum Brain Mapp; 2016 Jun; 37(6):2173-84. PubMed ID: 26956059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NLRP3 Activation Was Regulated by DNA Methylation Modification during Mycobacterium tuberculosis Infection.
    Wei M; Wang L; Wu T; Xi J; Han Y; Yang X; Zhang D; Fang Q; Tang B
    Biomed Res Int; 2016; 2016():4323281. PubMed ID: 27366746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.